Application of indocyanine green fluorescence imaging lymph node tracing technique in laparoscopic intrahepatic cholangiocarcinoma surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036268

Enrollment

Unknown

Registered

2020-08-22

Start date

2022-09-30

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrahepatic cholangiocarcinoma

Interventions

Control group:Routine lymph node dissection

ICG injection group:ICG-guided lymph node dissection

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients who are initially clinically diagnosed as ICC based on laboratory examinations and imaging examinations before surgery, and are confirmed to be ICC by pathology after surgery; (2) Child-Pugh classification of liver function before operation is A or B; (3) The preoperative judgment is consistent with complete tumor resection and successful operation; (4) The tumor is single, and there is no distant organ metastasis; (5) Sign the informed consent form; (6) The age is 18-75 years old;

Exclusion criteria

Exclusion criteria: (1) Abnormal bile metabolism or excretion; (2) Those who are allergic to iodine or ICG imaging agent; (3) Merge other malignant tumors; (4) Pregnant women; (5) Accept other treatments before surgery.

Design outcomes

Primary

Measure	Time frame
Lymph node detection rate and the number of resection;	—

Secondary

Measure	Time frame
overall survival;disease free survival;	—

Countries

China

Contacts

Public ContactLu lu

Huashan Hospital, Fudan University

lulu@huashan.org.cn+86 13701638183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026